These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


514 related items for PubMed ID: 30107147

  • 1. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Yang L, Chang Y, Cao P.
    Exp Cell Res; 2018 Oct 01; 371(1):231-237. PubMed ID: 30107147
    [Abstract] [Full Text] [Related]

  • 2. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
    Ji M, Lee EJ, Kim KB, Kim Y, Sung R, Lee SJ, Kim DS, Park SM.
    Oncol Rep; 2015 May 01; 33(5):2299-308. PubMed ID: 25813246
    [Abstract] [Full Text] [Related]

  • 3. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
    Song FN, Duan M, Liu LZ, Wang ZC, Shi JY, Yang LX, Zhou J, Fan J, Gao Q, Wang XY.
    PLoS One; 2014 May 01; 9(9):e108507. PubMed ID: 25268581
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan 01; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 5. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.
    World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tanaka S, Shiraha H, Nakanishi Y, Nishina S, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Nouso K, Yagi T, Yamamoto K.
    Int J Cancer; 2012 Dec 01; 131(11):2537-46. PubMed ID: 22488108
    [Abstract] [Full Text] [Related]

  • 8. HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells.
    Wang JH, Lee EJ, Ji M, Park SM.
    Oncol Rep; 2018 Jul 01; 40(1):346-354. PubMed ID: 29767267
    [Abstract] [Full Text] [Related]

  • 9. Valproic acid (VPA) promotes the epithelial mesenchymal transition of hepatocarcinoma cells via transcriptional and post-transcriptional up regulation of Snail.
    Wu L, Feng H, Hu J, Tian X, Zhang C.
    Biomed Pharmacother; 2016 Dec 01; 84():1029-1035. PubMed ID: 27768928
    [Abstract] [Full Text] [Related]

  • 10. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway.
    Liu D, Liu Y, Qi B, Gu C, Huo S, Zhao B.
    Cancer Med; 2021 Aug 01; 10(15):5235-5245. PubMed ID: 34160902
    [Abstract] [Full Text] [Related]

  • 11. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X.
    Sci Rep; 2016 Mar 16; 6():23091. PubMed ID: 26980408
    [Abstract] [Full Text] [Related]

  • 12. G9a and histone deacetylases are crucial for Snail2-mediated E-cadherin repression and metastasis in hepatocellular carcinoma.
    Hu Y, Zheng Y, Dai M, Wang X, Wu J, Yu B, Zhang H, Cui Y, Kong W, Wu H, Yu X.
    Cancer Sci; 2019 Nov 16; 110(11):3442-3452. PubMed ID: 31432592
    [Abstract] [Full Text] [Related]

  • 13. ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition.
    Xu T, Zhang J, Chen W, Pan S, Zhi X, Wen L, Zhou Y, Chen BW, Qiu J, Zhang Y, Yang Q, Feng X, Bai X, Liang T.
    Cancer Lett; 2016 Jul 28; 377(2):140-8. PubMed ID: 27126361
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway Epithelium.
    Park IH, Kang JH, Shin JM, Lee HM.
    PLoS One; 2016 Jul 28; 11(8):e0162058. PubMed ID: 27571418
    [Abstract] [Full Text] [Related]

  • 16. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han Y, Yin L, Cai C, Guo C, Shen H.
    Sci Rep; 2017 Jan 30; 7():41616. PubMed ID: 28134289
    [Abstract] [Full Text] [Related]

  • 17. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC.
    J Cell Mol Med; 2011 Mar 30; 15(3):691-700. PubMed ID: 20219012
    [Abstract] [Full Text] [Related]

  • 18. Effects of UPF1 expression on EMT process by targeting E‑cadherin, N‑cadherin, Vimentin and Twist in a hepatocellular carcinoma cell line.
    Li Y, Zhang T, Qin S, Wang R, Li Y, Zhou Z, Chen Y, Wu Q, Su F.
    Mol Med Rep; 2019 Mar 30; 19(3):2137-2143. PubMed ID: 30628676
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells via inducing Twist1 expression.
    Zhang XD, Dong XQ, Xu JL, Chen SC, Sun Z.
    Eur Rev Med Pharmacol Sci; 2017 Jul 30; 21(13):3061-3068. PubMed ID: 28742200
    [Abstract] [Full Text] [Related]

  • 20. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study.
    Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN.
    Exp Mol Pathol; 2011 Feb 30; 90(1):66-73. PubMed ID: 20969862
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.